Poloznikov, A. A., Nersisyan, S. A., Hushpulian, D. M., Kazakov, E. H., Tonevitsky, A. G., Kazakov, S. V., . . . Gazaryan, I. G. (2021). HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons. Front Pharmacol.
Citação norma ChicagoPoloznikov, Andrey A., et al. "HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons." Front Pharmacol 2021.
MLA citiranjePoloznikov, Andrey A., et al. "HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons." Front Pharmacol 2021.
Opozorilo: Ti citati niso vedno 100% točni.